Role of Monocyte-Acquired Hemozoin in Suppression of Macrophage Migration Inhibitory Factor in Children with Severe Malarial Anemia
暂无分享,去创建一个
James B. Hittner | Robert Ferrell | John M. Ong'echa | Douglas J. Perkins | Gordon A. Awandare | J. Hittner | J. Vulule | R. Ferrell | D. J. Perkins | C. Ouma | G. Awandare | G. Davenport | T. Were | J. Ong'echa | R. Otieno | Yamo Ouma | Collins Ouma | Tom Were | Richard Otieno | Christopher C. Keller | Gregory C. Davenport | John Vulule | C. Keller | Y. Ouma | D. Perkins
[1] J. Vulule,et al. Parasitemia, anemia, and malarial anemia in infants and young children in a rural holoendemic Plasmodium falciparum transmission area. , 2006, The American journal of tropical medicine and hygiene.
[2] S. Kaufmann,et al. Macrophage migration inhibitory factor (MIF) plays a pivotal role in immunity against Salmonella typhimurium , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[3] R. Bucala,et al. An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[4] B. Lowe,et al. Bacteraemia complicating severe malaria in children. , 1999, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[5] H. Ginsburg,et al. Impairment of Macrophage Functions after Ingestion of Plasmodium s Erythrocytes or Isolated Malarial Pigment , 2003 .
[6] C. Dye,et al. World Malaria Report, 2008. , 2008 .
[7] L. Tetley,et al. Protective effect on Leishmania major infection of migration inhibitory factor, TNF-alpha, and IFN-gamma administered orally via attenuated Salmonella typhimurium. , 1998, Journal of Immunology.
[8] G. Yap,et al. Production of Soluble Inhibitor of Erythropoiesis during Plasmodium chabaudi AS Infection in Resistant and Susceptible Mice a , 1991, Annals of the New York Academy of Sciences.
[9] M. Molyneux,et al. Clinical presentation of non-typhoidal Salmonella bacteraemia in Malawian children. , 2000, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[10] J. Nishihira,et al. Quantitation of macrophage migration inhibitory factor (MIF) using the one-step sandwich enzyme immunosorbent assay: elevated serum MIF concentrations in patients with autoimmune diseases and identification of MIF in erythrocytes. , 2000, International journal of molecular medicine.
[11] V. Nussenblatt,et al. Anemia and Interleukin-10, Tumor Necrosis Factor Alpha, and Erythropoietin Levels among Children with Acute, Uncomplicated Plasmodium falciparum Malaria , 2001, Clinical Diagnostic Laboratory Immunology.
[12] V. Adabayeri,et al. Low plasma concentrations of interleukin 10 in severe malarial anaemia compared with cerebral and uncomplicated malaria , 1998, The Lancet.
[13] B. Nahlen,et al. In vivo acquisition of hemozoin by placental blood mononuclear cells suppresses PGE2, TNF-alpha, and IL-10. , 2003, Biochemical and biophysical research communications.
[14] S. Abdalla. Hematopoiesis in human malaria. , 1990, Blood cells.
[15] J. Hittner,et al. A macrophage migration inhibitory factor promoter polymorphism is associated with high-density parasitemia in children with malaria , 2006, Genes and Immunity.
[16] J. Breman,et al. The intolerable burden of malaria: a new look at the numbers. , 2001, The American journal of tropical medicine and hygiene.
[17] P. Chomczyński,et al. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.
[18] J. Vulule,et al. Increased severe anemia in HIV-1-exposed and HIV-1-positive infants and children during acute malaria , 2006, AIDS.
[19] A. Satoskar,et al. Migration-Inhibitory Factor Gene-Deficient Mice Are Susceptible to Cutaneous Leishmania major Infection , 2001, Infection and Immunity.
[20] D. Weatherall,et al. The Anaemia of P. falciparum Malaria , 1980, British journal of haematology.
[21] K. Tracey,et al. Malaria-specific metabolite hemozoin mediates the release of several potent endogenous pyrogens (TNF, MIP-1 alpha, and MIP-1 beta) in vitro, and altered thermoregulation in vivo. , 1995, Journal of inflammation.
[22] Weltgesundheitsorganisation. World malaria report , 2005 .
[23] J. Oppenheim,et al. Biochemical characterization of Plasmodium falciparum hemozoin. , 1990, The American journal of tropical medicine and hygiene.
[24] R. Gbadegesin,et al. Intraleucocytic malaria pigment and clinical severity of malaria in children. , 1998, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[25] R. Snow,et al. Host-parasite interaction and morbidity in malaria endemic areas. , 1997, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[26] D. Weatherall,et al. The anaemia of Plasmodium falciparum malaria. , 1982, British medical bulletin.
[27] P. Silverman,et al. Inhibition of erythropoiesis by a soluble factor in murine malaria. , 1989, Experimental hematology.
[28] K. Tracey,et al. MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia , 1993, Nature.
[29] J. Hittner,et al. Reduced Peripheral PGE2 Biosynthesis in Plasmodium falciparum Malaria Occurs through Hemozoin-Induced Suppression of Blood Mononuclear Cell Cyclooxygenase-2 Gene Expression via an Interleukin-10-Independent Mechanism , 2004, Molecular medicine.
[30] B. Nahlen,et al. Immunity to placental malaria. IV. Placental malaria is associated with up-regulation of macrophage migration inhibitory factor in intervillous blood. , 2002, The Journal of infectious diseases.
[31] B. Nahlen,et al. A low interleukin-10 tumor necrosis factor-alpha ratio is associated with malaria anemia in children residing in a holoendemic malaria region in western Kenya. , 1999, The Journal of infectious diseases.
[32] H. Webster,et al. Plasmodium falciparum pigment induces monocytes to release high levels of tumor necrosis factor-alpha and interleukin-1 beta. , 1994, The American journal of tropical medicine and hygiene.
[33] Chris Newbold,et al. Relation between severe malaria morbidity in children and level of Plasmodium falciparum transmission in Africa , 1997, The Lancet.
[34] P. Arese,et al. Phagocytosis of the Malarial Pigment, Hemozoin, Impairs Expression of Major Histocompatibility Complex Class II Antigen, CD54, and CD11c in Human Monocytes , 1998, Infection and Immunity.
[35] I. Clark,et al. The pathophysiology of falciparum malaria. , 2003, Pharmacology & therapeutics.
[36] J. Hittner,et al. Differential Regulation of β-Chemokines in Children with Plasmodium falciparum Malaria , 2005, Infection and Immunity.
[37] P. Silverman,et al. Murine malaria decreases hemopoietic stem cells. , 1987, Blood.
[38] J. Bernhagen,et al. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor , 1994, The Journal of experimental medicine.
[39] M. McDevitt,et al. A critical role for the host mediator macrophage migration inhibitory factor in the pathogenesis of malarial anemia , 2006, The Journal of experimental medicine.
[40] Clark,et al. Possible importance of macrophage-derived mediators in acute malaria , 1981, Infection and immunity.
[41] J. David. Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. , 1966, Proceedings of the National Academy of Sciences of the United States of America.
[42] N. White,et al. Clearance kinetics of parasites and pigment-containing leukocytes in severe malaria. , 1996, Blood.
[43] B. Mordmüller,et al. Malaria pigment in leucocytes. , 1995, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[44] O. Rodrigues,et al. Reversible suppression of bone marrow response to erythropoietin in Plasmodium falciparum malaria , 1997, British journal of haematology.
[45] R. Steketee,et al. Effect of blood transfusion on survival among children in a Kenyan hospital , 1992, The Lancet.
[46] A. Satoskar,et al. Macrophage Migration Inhibitory Factor Contributes to Host Defense against Acute Trypanosoma cruzi Infection , 2006, Infection and Immunity.
[47] A. Satoskar,et al. Targeted Disruption of Migration Inhibitory Factor Gene Reveals Its Critical Role in Sepsis , 1999, The Journal of experimental medicine.
[48] M. Molyneux,et al. Tissue distribution of migration inhibitory factor and inducible nitric oxide synthase in falciparum malaria and sepsis in African children , 2003, Malaria Journal.
[49] J. Hittner,et al. Elevated Nitric Oxide Production in Children with Malarial Anemia: Hemozoin-Induced Nitric Oxide Synthase Type 2 Transcripts and Nitric Oxide in Blood Mononuclear Cells , 2004, Infection and Immunity.
[50] V. Poshyachinda,et al. Ferrokinetic studies and erythropoiesis in malaria. , 1969, Archives of internal medicine.
[51] P. Kremsner,et al. Increased erythropoietin production in children with severe malarial anemia. , 1995, The American journal of tropical medicine and hygiene.
[52] S N Wickramasinghe,et al. Blood and bone marrow changes in malaria. , 2000, Bailliere's best practice & research. Clinical haematology.
[53] P. Kremsner,et al. Reduced interleukin-12 and transforming growth factor-beta1 in severe childhood malaria: relationship of cytokine balance with disease severity. , 2000, The Journal of infectious diseases.
[54] R. Bucala,et al. Macrophage Migration Inhibitory Factor Release by Macrophages after Ingestion of Plasmodium chabaudi-Infected Erythrocytes: Possible Role in the Pathogenesis of Malarial Anemia , 2000, Infection and Immunity.
[55] T. Calandra,et al. Macrophage migration inhibitory factor: a regulator of innate immunity , 2003, Nature Reviews Immunology.
[56] D. Ray,et al. Glucocorticoids suppress macrophage migration inhibitory factor (MIF) expression in a cell-type-specific manner. , 2004, Journal of molecular endocrinology.
[57] J. Weinberg,et al. Monocyte chemotactic peptide receptor. Functional characteristics and ligand-induced regulation. , 1981, The Journal of clinical investigation.
[58] S. Looareesuwan,et al. Reduced levels of transforming growth factor-beta1, interleukin-12 and increased migration inhibitory factor are associated with severe malaria. , 2004, Acta tropica.
[59] P. V. Perkins,et al. Plasmodium falciparum incidence relative to entomologic inoculation rates at a site proposed for testing malaria vaccines in western Kenya. , 1994, The American journal of tropical medicine and hygiene.
[60] P. Arese,et al. Malarial pigment (haemozoin): a very active 'inert' substance. , 1997, Annals of tropical medicine and parasitology.
[61] J. Hittner,et al. Disorders of Erythropoiesis • Brief Report Suppression of RANTES in children with Plasmodium falciparum malaria Tom , 2022 .
[62] J. Bernhagen,et al. Migration inhibitory factor induces killing of Leishmania major by macrophages: dependence on reactive nitrogen intermediates and endogenous TNF-alpha. , 1998, Journal of immunology.
[63] A. Monto,et al. Effect of Plasmodium falciparum parasitemia density on hemoglobin concentrations among full-term, normal birth weight children in western Kenya, IV. The Asembo Bay Cohort Project. , 2000, The American journal of tropical medicine and hygiene.
[64] D. Ferguson,et al. Intraleucocytic malaria pigment and prognosis in severe malaria. , 1995, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[65] R. Bucala,et al. Protection from septic shock by neutralization of macrophage migration inhibitory factor , 2000, Nature Medicine.
[66] B. Lell,et al. Low Interleukin-12 Activity in Severe Plasmodium falciparum Malaria , 2000, Infection and Immunity.
[67] L. Tetley,et al. Protective Effect on Leishmania major Infection of Migration Inhibitory Factor, TNF-α, and IFN-γ Administered Orally via Attenuated Salmonella typhimurium , 1998, The Journal of Immunology.
[68] B. Nahlen,et al. Immunohistological Characterization of Macrophage Migration Inhibitory Factor Expression in Plasmodium falciparum-Infected Placentas , 2005, Infection and Immunity.
[69] N. Petrovsky,et al. Response of serum macrophage migration inhibitory factor levels to stimulation or suppression of the hypothalamo-pituitary-adrenal axis in normal subjects and patients with Cushing's disease. , 2002, The Journal of clinical endocrinology and metabolism.
[70] K. Diane. Schooley, and L. , 1994 .
[71] J. Hittner,et al. Decreased circulating macrophage migration inhibitory factor (MIF) protein and blood mononuclear cell MIF transcripts in children with Plasmodium falciparum malaria. , 2006, Clinical immunology.
[72] M. McDevitt,et al. The anemia of malaria infection: role of inflammatory cytokines. , 2004, Current hematology reports.
[73] A. Dicko,et al. Association of intraleukocytic Plasmodium falciparum malaria pigment with disease severity, clinical manifestations, and prognosis in severe malaria. , 2003, The American journal of tropical medicine and hygiene.